Patents Examined by Jean F Vollano
  • Patent number: 6680401
    Abstract: The invention relates to processes for the synthesis of aryl or alkene borates which comprises reacting: (i) an olefinic compound having a halogen or halogen-like substituent in a vinylic substitution position, or (ii) an aromatic ring having a halogen or halogen-like substituent in a ring substitution position, with a disubstituted monohydroborane in the presence of a Group 8-11 metal catalyst. The invention also relates to the use of these borates in coupling reactions. The invention further relates to certain disubstituted monohydroboranes and aryl or alkene borates.
    Type: Grant
    Filed: August 13, 2001
    Date of Patent: January 20, 2004
    Assignee: Commonwealth Scientific and Industrial Research Organisation
    Inventors: Sebastian Mario Marcuccio, Mary Rodopoulos, Helmut Weigold
  • Patent number: 6680411
    Abstract: A carborane supercluster consisting of carborane (C2B10H12) as its constituent unit expressed as a molecular formula C2mB10mH12m-x, where x is a positive integer (i.e., x=1, 2, 3, . . . ) and m is an integer greater than unity (i.e., m=2, 3, . . . ). The parameter x represents the count of removed or detached hydrogen atoms. The parameter a represents the count of the clusters linked together. To produce the supercluster, carborane (C2B10H12) is ionized in a reaction chamber to generate carborane ions and then, the carborane ions thus generated are successively reacted with the remaining neutral (i.e., non-ionized) carborane (C2B10H12), thereby generating the carborane supercluster. Preferably, the cluster of the carborane consists of at least two of o-carborane, m-carborane, and p-carborane.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: January 20, 2004
    Assignees: Agency of Industrial Science and Technology, NEC Corporation
    Inventors: Toshihiko Kanayama, Hidefumi Hiura
  • Patent number: 6677478
    Abstract: The conventional process for the production of a peracetic acid product, wherein hydrogen peroxide, acetic acid and water are fed into an aqueous reaction medium containing hydrogen peroxide, acetic acid, peracetic acid and an acid catalyst, wherein hydrogen peroxide and acetic acid react in the presence of the acid catalyst and form peracetic acid, and an aqueous peracetic acid concentrate is removed continuously from the reaction medium by distillation, has now been improved by feeding the acid catalyst continuously into the reaction medium and by withdrawing continuously a portion of the reaction medium as a bottom product. When the through flow of the reaction medium is thus increased, it is purified of impurities threatening the safety of the process. If the amount of acid catalyst in the reaction medium is further decreased, a product suitable, for example, for disinfection is obtained from the bottom product.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: January 13, 2004
    Assignee: Kemira Chemicals Oy
    Inventors: Seppo Pohjanvesi, Eva-Liisa Mustonen, Arto Pukkinen, Reino Lehtinen
  • Patent number: 6677477
    Abstract: The reaction medium and distillate of a conventional continuous peracetic acid process can be combined into a stable peracetic acid product if the acid catalyst present in the reaction medium is neutralized.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: January 13, 2004
    Assignee: Kemira Chemicals Oy
    Inventors: Seppo Pohjanvesi, Arto Pukkinen, Teemu Sodervall
  • Patent number: 6673961
    Abstract: Processes for making particularly branched, especially monomethyl-branched or nongeminal dimethyl-branched surfactants used in cleaning products; preferred processes comprising particular combinations of two or more adsorptive separation steps and, more preferably, particular alkylation steps; products of such processes, including certain modified alkylbenzenes, modified alkylbenzenesulfonate surfactants, and consumer cleaning products, especially laundry detergents, containing them. Preferred processes herein more specifically use specific, unconventional sequences of sorptive separation steps to secure certain branched hydrocarbon fractions which are used in further process steps as alkylating agents for arenes or for other useful surfactant-making purposes. Surprisingly, such fractions can even be derived from effluents from current linear alkylbenzene manufacture.
    Type: Grant
    Filed: November 26, 2002
    Date of Patent: January 6, 2004
    Assignee: The Procter & Gamble Company
    Inventors: Daniel Stedman Connor, Jeffrey John Scheibel, James Charles Theophile Roger Burckett-St. Laurent, Thomas Anthony Cripe, Kevin Lee Kott, Phillip Kyle Vinson
  • Patent number: 6670401
    Abstract: Polysubstituted indan-1-ol compounds, methods for their preparation; and methods for their use are disclosed herein. In particular, the invention relates to polysubstituted indan-1-ol compounds of the formula I and their physiologically acceptable salts. The compounds are useful, for example, as anorectics.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: December 30, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Patent number: 6666975
    Abstract: The present invention is directed to a fast-acting, aqueous phase chemical treatment for reducing the emission of hydrogen sulfide odor from an aqueous medium, e.g., a wastewater or pulping and paper making medium, to the vapor phase. This invention comprises adding an effective amount for the purpose of glyoxal to the desired hydrogen sulfide-containing medium.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: December 23, 2003
    Assignee: GE Betz, Inc.
    Inventors: Zhuo Chen, Stephen R. Vasconcellos
  • Patent number: 6667345
    Abstract: Derivatives of C2-substituted indan-1-ol compounds of the formula I: its physiologically acceptable salts, and its physiologically functional derivatives for the prophylaxis or treatment of obesity are disclosed herein. Compositions comprising the same, methods for preparing the instant compounds, and methods for reducing weight in mammals and for the prophylaxis or treatment of obesity are also described.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: December 23, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Patent number: 6667421
    Abstract: This invention relates to a process for the production of an aryl thiol, which comprises hydrogenating an aryl sulfonyl chloride in a solvent in the presence of a palladium catalyst and a base whose conjugate acid has a pKa of about 2 or greater, wherein the base is selected from the group consisting of ionic bases soluble in water and tertiary amines soluble in the solvent, the tertiary amines not having a methyl group attached to the amine nitrogen.
    Type: Grant
    Filed: August 28, 2002
    Date of Patent: December 23, 2003
    Assignee: E. I. du Pont de Nemours and Company
    Inventor: Stephen E. Jacobson
  • Patent number: 6667340
    Abstract: The present invention relates to the preparation and biological activity of 3-deoxy-Dmyo-inositol ether lipid analogs as inhibitors of phosphatidylinositol-3-kinase signaling and cancer cell growth. The compounds of the present invention are useful as anti-tumor 5 agents which effectively inhibit the growth of mammalian cells.
    Type: Grant
    Filed: June 12, 2001
    Date of Patent: December 23, 2003
    Assignees: Arizona Board of Regents on behalf of the University of Arizona, Georgetown University School of Medicine
    Inventors: Alan P. Kozikowski, Lixin Qiao, Garth Powis
  • Patent number: 6664365
    Abstract: The present invention provides a novel salt useful as an active species in an organic reaction and represented by the following chemical formula (1): wherein n stands for an integer of from 1 to 8, Zn− represents an n-valent anion of an active hydrogen compound, a, b, c and d each stands for a positive integer, and Rs represent the same or different hydrocarbon groups. Also disclosed is a simple and efficient process for producing a poly(alkylene oxide) by polymerizing an alkylene oxide compound in the presence of the salt represented by the chemical formula (1).
    Type: Grant
    Filed: September 3, 1999
    Date of Patent: December 16, 2003
    Inventors: Tadahito Nobori, Masahiro Kouno, Toshiaki Suzuki, Kazumi Mizutani, Shinji Kiyono, Yoshiho Sonobe, Usaji Takaki
  • Patent number: 6664426
    Abstract: New boron icosahedral ethers and esters formed from Cs2[closo-B12(OH)12],; Cs[closo-1-H-1-CB11(OH)11]; and closo-1,12-H2-1,12-C2B10(OH)10 are disclosed. Also set forth are their preparation by reacting the icosahedral boranes [closo-B12H12]2−, [closo-1-CB11H12]− and closo-1,12-(CH2OH)2-1,12-C2B10H10 with an acid anhdride or acid chloride to form the ester or an alkylating agent to form the ether.
    Type: Grant
    Filed: June 12, 2000
    Date of Patent: December 16, 2003
    Assignee: The Regents of the University of California
    Inventors: M. Frederick Hawthorne, Toralf Peymann, Andreas Maderna
  • Patent number: 6664259
    Abstract: This invention relates to novel compounds of Formula (I) to (VII), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
    Type: Grant
    Filed: September 6, 2002
    Date of Patent: December 16, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Katherine Louisa Widdowson, Qi Jin
  • Patent number: 6660888
    Abstract: There are disclosed a disulfone compound of formula (1): wherein Ar denotes an aryl group that may have a substituent, R1 denotes a hydrogen atom or a protective group of a hydroxyl group and the wavy line means that the disulfone compound is an E or Z geometrical isomer or a mixture thereof, a method for producing the same, intermediate compounds therefore and a process for producing retinol through the disulfone compound.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: December 9, 2003
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Toshiya Takahashi, Shinzo Seko, Kazutaka Kimura, Noriyuki Doi, Naoto Konya
  • Patent number: 6660882
    Abstract: The present invention provides a process for the preparation of highly pure 2-Methyl-2-propene-1-sulfonic acid, sodium salt in high yield, with very low iron content, by the reaction of distilled sulfur trioxide complexed with a Lewis base in a halogentated solvent, the unreacted sulfur trioxide vapors being removed from the reactor before the mixture is treated with liquefied isobutylene, and neutralization by a base with an iron content within the range of 0 to 20 ppm.
    Type: Grant
    Filed: March 18, 2002
    Date of Patent: December 9, 2003
    Assignee: Council of Scientific and Industrial Research
    Inventors: Prashant Purushottam Barve, Sunil Shankar Joshi, Ravindra William Shinde, Shrikant Madhukar Ghike, Milind Yashwant Gupte, Chandrashekhar Narayan Joshi, Raghavendra Venkatrao Naik
  • Patent number: 6657086
    Abstract: Embodiments of the invention relate to C2-substituted indan-1-ols and to their physiologically acceptable salts and physiologically functional derivatives. Compounds of embodiments of the invention may include compounds of formula I in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds are suitable, for example, for use as anorectics.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: December 2, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Gerhard Jaehne, Volker Krone, Martin Bickel, Matthias Gossel
  • Patent number: 6657072
    Abstract: The invention relates to a method of preparing lithium complex salts and their intermediaries and to the use of these in electrolytes.
    Type: Grant
    Filed: July 10, 2002
    Date of Patent: December 2, 2003
    Assignee: Merck Patent Gesellschaft mit beschränkter Haftung
    Inventors: Andrei Leonov, Armin de Meijere, Michael Schmidt
  • Patent number: 6657081
    Abstract: The invention relates to new calixarenes according to the formula: wherein: R1 is an alkyl or aryl group, or a hydrogen atom, R2 and R3, which may be identical or different, are alkyl or aryl groups, n is an integer ranging from 2 to 8, and p is an integer ranging from 4 to 8. Said calixarenes may be used to extract actinides and lanthanides from aqueous solutions.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: December 2, 2003
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Jean-François Dozol, Alejandro Garcia Carrera, Volker Bohmer, Susan E. Matthews
  • Patent number: 6657076
    Abstract: A process for the preparation of salts of substituted or unsubstituted methylene bisphosphonic acids by hydrolysing the corresponding acid ester with hydrochloric acid, removing water from the acid azeotropically prior to addition of an amine or a base to produce the resultant salt in good yield.
    Type: Grant
    Filed: March 14, 2002
    Date of Patent: December 2, 2003
    Assignee: AstraZeneca UK Limited
    Inventor: Mark Purdie
  • Patent number: 6653485
    Abstract: 3,3′-Substituted chiral biaryl phosphine and phosphinite ligands and metal complexes based on such chiral ligands useful in asymmetric catalysis are disclosed. The metal complexes are useful as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation, isomerization, cyclopropanation, Diels-Alder reaction, Heck reaction, isomerization, Aldol reaction, Michael addition, epoxidation, kinetic resolution and [m+n] cycloaddition. The metal complexes are particularly effective in Ru-catalyzed asymmetric hydrogenation of beta-ketoesters to beta-hydroxyesters and Ru-catalyzed asymmetric hydrogenation of enamides to beta amino acids.
    Type: Grant
    Filed: November 16, 2001
    Date of Patent: November 25, 2003
    Assignee: The Penn State Research Foundation
    Inventor: Xumu Zhang